We're delighted to announce Professor Kenneth Harris (UCL Queen Square Institute of Neurology) has been awarded the prize for his revolutionary contributions to neuroscience.

A new research programme at UCL Queen Square Institute of Neurology will investigate novel biomarkers for Multiple System Atrophy (MSA)

A pioneering experimental treatment for motor neurone disease (MND), developed by UCL spinout Trace Neuroscience, will be trialled in humans as part of a new international clinical programme.

From 2019 to 2024, the ICGNMD’s first MRC-funded award supported early career clinical fellows around the world to develop clinical academic research expertise in neuromuscular diseases.

By cutting down deliveries, you can lower your lab’s carbon footprint, reduce clutter and admin and free up researchers to focus on discovering new cures and treatments. Learn how

UCL Queen Square MND Centre Seventh ALS/MND International Symposium in Partnership with the UK MND Research Institute Emerging themes in ALS/MND research and in the clinic

The London Mitochondrial Centre is hosting a one-day symposium.

A research team at UCL Queen Square Institute of Neurology has identified a previously unknown genetic cause of Charcot-Marie-Tooth disease (CMT)

BDNF promotes axon-regenerative gene expression, RNA metabolism, and kinase signaling in motor neurons.

jobs.ac.uk now advertising a PhD Studentship: Genetic Modifiers to Untangle Disease Mechanisms of RFC1 Repeat Expansion Visit jobs.ac.uk to apply and to browse more PhD opportunities.

UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).